Literature DB >> 23201400

Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa.

A Nakamura1, K Miyake, S Misawa, Y Kuno, T Horii, S Kondo, Y Tabe, A Ohsaka.   

Abstract

The objective of this study was to explore independent risk factors for the isolation of multidrug-resistant (MDR) Pseudomonas aeruginosa in a Japanese university hospital between January 1997 and December 2010. MDR P. aeruginosa was defined when the organism was resistant or intermediately susceptible to all five antimicrobials tested. In all, 159 patients with MDR P. aeruginosa were identified over the 14-year period. Multivariate logistic regression analysis revealed that prolonged hospital stay, prior exposure to meropenem and fluoroquinolones, and patients suffering from diabetes mellitus or receiving surgery were predictive risk factors for the isolation of MDR P. aeruginosa.
Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201400     DOI: 10.1016/j.jhin.2012.10.005

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study.

Authors:  Mohammed J Al-Jaghbeer; Julie Ann Justo; William Owens; Joseph Kohn; P Brandon Bookstaver; Jennifer Hucks; Majdi N Al-Hasan
Journal:  Infection       Date:  2018-05-11       Impact factor: 3.553

2.  Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia.

Authors:  Johanna M Vanegas; Astrid V Cienfuegos; Ana M Ocampo; Lucelly López; Helena del Corral; Gustavo Roncancio; Patricia Sierra; Lina Echeverri-Toro; Sigifredo Ospina; Natalia Maldonado; Carlos Robledo; Andrea Restrepo; J Natalia Jiménez
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

3.  Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolated from Blood Samples and Antibiotic Utilization in a University Hospital in Japan.

Authors:  Ito Kato; Fumie Fujimoto; Yoshimi Higurashi; Ryo Yamaguchi; Kazuo Takayama; Masashi Suzuki; Shu Okugawa; Mitsuhiro Okazaki; Kyoji Moriya
Journal:  Infect Dis Ther       Date:  2015-05-20

4.  Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis.

Authors:  Hamid Vaez; Amin Salehi-Abargouei; Zahra Rashki Ghalehnoo; Farzad Khademi
Journal:  J Glob Infect Dis       Date:  2018 Oct-Dec

Review 5.  Direct Measurement of Performance: A New Era in Antimicrobial Stewardship.

Authors:  Majdi N Al-Hasan; Hana Rac Winders; P Brandon Bookstaver; Julie Ann Justo
Journal:  Antibiotics (Basel)       Date:  2019-08-24

6.  Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.

Authors:  Gowri Raman; Esther E Avendano; Jeffrey Chan; Sanjay Merchant; Laura Puzniak
Journal:  Antimicrob Resist Infect Control       Date:  2018-07-04       Impact factor: 4.887

7.  Type 2 diabetes mellitus and antibiotic-resistant infections: a systematic review and meta-analysis.

Authors:  Rodrigo M Carrillo-Larco; Cecilia Anza-Ramírez; Giancarlo Saal-Zapata; David Villarreal-Zegarra; Jessica Hanae Zafra-Tanaka; Cesar Ugarte-Gil; Antonio Bernabé-Ortiz
Journal:  J Epidemiol Community Health       Date:  2021-07-29       Impact factor: 3.710

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.